Accelerate Site Startup With the Leading Renal SMO

With one of the world’s largest networks of nephrology clinical research investigators and sites, Frenova is the world’s leading site network operating at the intersection of renal research and care. Through our connection to Fresenius Medical Care, we have access to one of the largest ESRD patient populations. At the same time, with 25+ years of renal research experience, our expert team has built up an incomparable knowledge base in clinical trial site management and research protocol design for renal studies. This unique position ensures that Frenova provides effective, real-world tested and reliable recommendations for planning and executing studies that include patients at all stages of CKD, and those with related disorders. Tap into our network of global research sites for better investigator selection, easier clinical trial recruitment and faster study startup.

Frenova’s Site Network

We are a leading manager of nephrology-oriented sites. Sites within our network are primed for rapid study startup and are ideally suited to deliver the reliable performance and high-quality data you need to gain critical insights and advance the science of renal therapies.

Map background FRENOVAS SITE NETWORK (USA) 550+ Investigators 330+ Sites Frenova Renal Research920 Winter StreetWaltham, MA 02451-1457844.CKD.ESRD (844.253.3773) OUR GLOBAL NETWORK OF SITES(EMEA, LATAM, APAC) 1,300+ Clinicians 45+ Countries Frenova International Clinical Research ServicesFresenius Medical Care Deutschland GmbHElse-Kröner-Strasse 161352 Bad Homburg v.d.H.+49 (0) 6172 608 94512frenova@fmc-ag.com

North America

Frenova Renal Research

920 Winter Street
Waltham, MA 02451-1457

844.CKD.ESRD (844.253.3773)

International

Frenova International Clinical Research Services

Fresenius Medical Care Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg v.d.H.

+49 (0) 6172 608 94512
frenova@fmc-ag.com

When you’re looking for the best renal intelligence to find sites, patients and data for your next trial,
FRENOVA KNOWS.